A Study of Minirin Melt in 24 Months Treatment in Patients With Nocturia

A Prospective Safety Study in 24 Months Treatment of Nocturia With Minirin Melt in Clinical Practice in the Czech Republic

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01552395

Enrollment

4136

Registered

2012-03-13

Start date

2012-03-31

Completion date

2016-04-30

Last updated

2016-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nocturia

Brief summary

A Confirmation of the Safety Profile for Minirin Melt in Clinical Practice

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* nocturia

Exclusion criteria

* habitual or psychogenic polydipsia, * known or suspected cardiac insufficiency * other conditions requiring treatment with diuretics * moderate and severe renal insufficiency * known hyponatremia * syndrome of inappropriate ADH secretion

Design outcomes

Primary

Measure	Time frame
Number of patients with adverse events	24 months

Secondary

Measure	Time frame
Number of changes in dosage regime	24 months

Countries

Czechia

Outcome results